These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16026156)

  • 1. The apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase.
    Dahms TE; Sainz G; Giroux EL; Caperelli CA; Smith JL
    Biochemistry; 2005 Jul; 44(29):9841-50. PubMed ID: 16026156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase.
    Almassy RJ; Janson CA; Kan CC; Hostomska Z
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6114-8. PubMed ID: 1631098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.
    Zhang Y; Desharnais J; Greasley SE; Beardsley GP; Boger DL; Wilson IA
    Biochemistry; 2002 Dec; 41(48):14206-15. PubMed ID: 12450384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton transfer dynamics of GART: the pH-dependent catalytic mechanism examined by electrostatic calculations.
    Morikis D; Elcock AH; Jennings PA; McCammon JA
    Protein Sci; 2001 Nov; 10(11):2379-92. PubMed ID: 11604543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure of Escherichia coli PurT-encoded glycinamide ribonucleotide transformylase.
    Thoden JB; Firestine S; Nixon A; Benkovic SJ; Holden HM
    Biochemistry; 2000 Aug; 39(30):8791-802. PubMed ID: 10913290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic mechanism of Escherichia coli glycinamide ribonucleotide transformylase probed by site-directed mutagenesis and pH-dependent studies.
    Shim JH; Benkovic SJ
    Biochemistry; 1999 Aug; 38(31):10024-31. PubMed ID: 10433709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray crystal structure of glycinamide ribonucleotide synthetase from Escherichia coli.
    Wang W; Kappock TJ; Stubbe J; Ealick SE
    Biochemistry; 1998 Nov; 37(45):15647-62. PubMed ID: 9843369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution.
    Klein C; Chen P; Arevalo JH; Stura EA; Marolewski A; Warren MS; Benkovic SJ; Wilson IA
    J Mol Biol; 1995 May; 249(1):153-75. PubMed ID: 7776369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian glycinamide ribonucleotide transformylase. Kinetic mechanism and associated de novo purine biosynthetic activities.
    Caperelli CA
    J Biol Chem; 1989 Mar; 264(9):5053-7. PubMed ID: 2925682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.
    Zhang Y; Desharnais J; Marsilje TH; Li C; Hedrick MP; Gooljarsingh LT; Tavassoli A; Benkovic SJ; Olson AJ; Boger DL; Wilson IA
    Biochemistry; 2003 May; 42(20):6043-56. PubMed ID: 12755606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human glycinamide ribonucleotide transformylase domain: purification, characterization, and kinetic mechanism.
    Caperelli CA; Giroux EL
    Arch Biochem Biophys; 1997 May; 341(1):98-103. PubMed ID: 9143358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human trifunctional enzyme of de novo purine biosynthesis: heterologous expression, purification, and preliminary characterization.
    Poch MT; Qin W; Caperelli CA
    Protein Expr Purif; 1998 Feb; 12(1):17-24. PubMed ID: 9473452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A.
    Su Y; Yamashita MM; Greasley SE; Mullen CA; Shim JH; Jennings PA; Benkovic SJ; Wilson IA
    J Mol Biol; 1998 Aug; 281(3):485-99. PubMed ID: 9698564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of avian AICAR transformylase with a multisubstrate adduct inhibitor beta-DADF identifies the folate binding site.
    Wolan DW; Greasley SE; Wall MJ; Benkovic SJ; Wilson IA
    Biochemistry; 2003 Sep; 42(37):10904-14. PubMed ID: 12974624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the structural and functional modularity of glycinamide ribonucleotide formyltransferases.
    Lee SG; Lutz S; Benkovic SJ
    Protein Sci; 2003 Oct; 12(10):2206-14. PubMed ID: 14500878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into inhibitor design from the crystal structure and NMR studies of Escherichia coli GAR transformylase in complex with beta-GAR and 10-formyl-5,8,10-trideazafolic acid.
    Greasley SE; Yamashita MM; Cai H; Benkovic SJ; Boger DL; Wilson IA
    Biochemistry; 1999 Dec; 38(51):16783-93. PubMed ID: 10606510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native-state conformational dynamics of GART: a regulatory pH-dependent coil-helix transition examined by electrostatic calculations.
    Morikis D; Elcock AH; Jennings PA; McCammon JA
    Protein Sci; 2001 Nov; 10(11):2363-78. PubMed ID: 11604542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbocyclic glycinamide ribonucleotide is a substrate for glycinamide ribonucleotide transformylase.
    Caperelli CA; Price MF
    Arch Biochem Biophys; 1988 Jul; 264(1):340-2. PubMed ID: 3395127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein structure-based design, synthesis, and biological evaluation of 5-thia-2,6-diamino-4(3H)-oxopyrimidines: potent inhibitors of glycinamide ribonucleotide transformylase with potent cell growth inhibition.
    Varney MD; Palmer CL; Romines WH; Boritzki T; Margosiak SA; Almassy R; Janson CA; Bartlett C; Howland EJ; Ferre R
    J Med Chem; 1997 Aug; 40(16):2502-24. PubMed ID: 9258357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy.
    Chen P; Schulze-Gahmen U; Stura EA; Inglese J; Johnson DL; Marolewski A; Benkovic SJ; Wilson IA
    J Mol Biol; 1992 Sep; 227(1):283-92. PubMed ID: 1522592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.